Odyssey Therapeutics logo

Odyssey Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series C

Recent Raise

$101M


Odyssey Therapeutics is a biotech firm specializing in developing precision immunomodulators and oncology medicines, with plans to advance multiple therapeutic programs into clinical studies.

Total Funding

$487M

Headquarters

Boston, USA

Founded

2021

Focus Areas

Biotechnology
Immunomodulators
Oncology Medicines
Clinical Trials
Therapeutic Innovation
Drug Discovery

Investors